Developing new therapeutic solutions.

In this episode, we are joined by Sam Whitehouse, CEO at LIGHTOX

All of their products have chemistry at the heart of their origin and design, Lightox are able to take this chemistry and look for application opportunities in a number of fields, and by working collaboratively, they seek to raise revenues from a number of sources. By coupling the molecules to targeting agents they can direct their probes and cell killing drugs to specific cell types or intracellular components.

During the conversation we talk about:

• Understanding the two main research areas
• Cost of care associated in this space
• Project APOLLO
• and an exciting 2021 for Sam